April 6, 2020

COVID-19 has been a disruptive force for all countries, industries and families.  Drug development has not been immune, as sponsors, CROs and sites have seen operational and financial disruptions.  Like most CROs, Clinipace is assessing data to get a better h...

Please reload

December 3, 2018

Please reload